VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 167 filers reported holding VERACYTE INC in Q2 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,305,585 | +19.9% | 600,926 | -3.4% | 0.11% | +24.7% |
| Q1 2023 | $12,769,973 | -10.6% | 622,146 | +3.3% | 0.09% | -7.3% |
| Q4 2022 | $14,288,256 | +127.3% | 602,146 | +59.0% | 0.10% | +118.2% |
| Q3 2022 | $6,286,000 | -16.6% | 378,663 | 0.0% | 0.04% | -29.0% |
| Q2 2022 | $7,536,000 | -27.8% | 378,663 | 0.0% | 0.06% | -12.7% |
| Q1 2022 | $10,440,000 | +58.6% | 378,663 | +86.9% | 0.07% | +14.5% |
| Q3 2020 | $6,582,000 | +21.6% | 202,595 | -3.1% | 0.06% | +8.8% |
| Q2 2020 | $5,414,000 | +21.4% | 209,015 | +27.9% | 0.06% | +16.3% |
| Q1 2020 | $4,460,000 | -2.2% | 163,424 | +0.0% | 0.05% | 0.0% |
| Q4 2019 | $4,562,000 | +108.8% | 163,391 | +79.4% | 0.05% | +69.0% |
| Q3 2019 | $2,185,000 | -5.6% | 91,062 | +11.6% | 0.03% | 0.0% |
| Q2 2019 | $2,315,000 | +49.4% | 81,562 | +31.6% | 0.03% | +45.0% |
| Q1 2019 | $1,550,000 | – | 61,962 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |